A sale of Life Technologies (LIFE) could be back on, with the biomedical laboratory equipment maker reportedly in talks with a consortium of private-equity firms that includes Blackstone (BX) and Carlyle (CG). Last month, prospects for a sale looked dim, as potential suitors had been put off by the run up in Life's share price, which has given it a market cap of $10.6B and could still be an obstacle to a deal.
A sale of Life Technologies (LIFE) could be back on, with the biomedical laboratory equipment...
From other sites
Video at CNBC.com (Jun 28, 2016)
Video at CNBC.com (May 27, 2016)
Video at CNBC.com (Apr 7, 2016)
at CNBC.com (Nov 5, 2014)
at CNBC.com (Oct 22, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs